1. Abad, Etna, Sandoz, Jérémy, Romero, Gerard, Sdelci, Sara, Janic, Ana. 2024. The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability. In Journal of experimental & clinical cancer research : CR, 43, 127. doi:10.1186/s13046-024-03045-4. https://pubmed.ncbi.nlm.nih.gov/38685100/
2. Zhang, Zhen, Zhang, Luoyan, Wang, Bin, Zhang, Yunhong, Li, Xia. 2019. RNF144B inhibits LPS-induced inflammatory responses via binding TBK1. In Journal of leukocyte biology, 106, 1303-1311. doi:10.1002/JLB.2A0819-055R. https://pubmed.ncbi.nlm.nih.gov/31509299/
3. Du, Li, Chen, Wei, Li, Chunyun, Cui, Yinghong, He, Zuping. 2022. RNF144B stimulates the proliferation and inhibits the apoptosis of human spermatogonial stem cells via the FCER2/NOTCH2/HES1 pathway and its abnormality is associated with azoospermia. In Journal of cellular physiology, 237, 3565-3577. doi:10.1002/jcp.30813. https://pubmed.ncbi.nlm.nih.gov/35699595/
4. Wang, C-B, Wang, Y, Wang, J-J, Guo, X-L. . LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p. In European review for medical and pharmacological sciences, 24, 1007-1022. doi:10.26355/eurrev_202002_20151. https://pubmed.ncbi.nlm.nih.gov/32096180/